Bildkälla: Stockfoto

Active Biotech: Orphan Drug Designation for Tasquinimod in Myelofibrosis in the US - Redeye

Redeye has a positive view of Active Biotech’s obtaining orphan drug status. We discuss the benefits in our comment.

Redeye has a positive view of Active Biotech’s obtaining orphan drug status. We discuss the benefits in our comment.
Börsvärldens nyhetsbrev
ANNONSER